Why women experience Alzheimer’s disease differently from men

Published by Nature Outlook Magazine| 14 April 2025 | BY Katherine Bourzac

The first recorded example of Alzheimer’s disease involved Auguste Deter, a woman who died in Frankfurt, Germany, in April 1906, after experiencing memory loss and great anguish.

In physician Alois Alzheimer’s 1907 paper1 describing Deter’s symptoms, he wrote that she “is completely delirious, drags around her bedding, calls her husband and daughter and seems to suffer from auditory hallucinations. Often she screamed for many hours”. Alzheimer examined her brain under a microscope after her death, and described what are now considered the hallmarks of the disease: deposits of the protein amyloid-β, known as plaques, and dense fibrils of the protein tau, now called neurofibrillary tangles. Deter died in a psychiatric institution, curled up in the fetal position, of sepsis caused by bedsores.

continue reading…

 


Support the advancement of brain and mental health:

Donate here or with TWINT


We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.